Skip to content
← Full study record

NCT03687125 · OUTCOME

Phase 1 and 2: Change From Baseline in Clinical Serum Chemistry Tests: Liver Function Parameters

Tinostamustine Conditioning and Autologous Stem Cell · Source last updated 2021-06-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
units per liter (U/L)
Interval / dispersion
Standard Deviation
Time frame
Baseline (Day -1), Day 100

What was measured

Clinical serum chemistry tests included liver function parameters i.e. Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Aspartate aminotransferase, (AST) and Lactate dehydrogenase. Change from baseline in clinical serum chemistry tests i.e. liver function parameters at Day 100 were reported.

Analysis population: Safety population included all participants who received tinostamustine. The study was early terminated on 17 April 2019, due to safety signals during Phase 1, participants were not enrolled in Phase 2. Here, number analyzed refers to the number of participants with available data for each specified category.

Groups in this outcome

Tinostamustine 180 mg/m^2

Participants received single dose of tinostamustine 180 mg/m\^2 IV injection on Day -1 followed by ASCT on Day 1.

Tinostamustine 220 mg/m^2

Participants received single dose of tinostamustine 220 mg/m\^2 IV injection on Day -1 followed by ASCT on Day 1.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Tinostamustine 180 mg/m^23
Tinostamustine 220 mg/m^23

Reported measurements

ALT: Change at Day 100

Analysis denominator · Participants

GroupSource count
Tinostamustine 180 mg/m^23
Tinostamustine 220 mg/m^23
Values in units per liter (U/L) · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Tinostamustine 180 mg/m^24.01.73Not reportedNot reportedNot reported
Tinostamustine 220 mg/m^20.33.06Not reportedNot reportedNot reported
ALP: Change at Day 100

Analysis denominator · Participants

GroupSource count
Tinostamustine 180 mg/m^23
Tinostamustine 220 mg/m^23
Values in units per liter (U/L) · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Tinostamustine 180 mg/m^210.76.81Not reportedNot reportedNot reported
Tinostamustine 220 mg/m^214.75.13Not reportedNot reportedNot reported
AST: Change at Day 100

Analysis denominator · Participants

GroupSource count
Tinostamustine 180 mg/m^23
Tinostamustine 220 mg/m^23
Values in units per liter (U/L) · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Tinostamustine 180 mg/m^23.01.00Not reportedNot reportedNot reported
Tinostamustine 220 mg/m^22.04.36Not reportedNot reportedNot reported
Lactate dehydrogenase: Change at Day 100

Analysis denominator · Participants

GroupSource count
Tinostamustine 180 mg/m^22
Tinostamustine 220 mg/m^22
Values in units per liter (U/L) · Interval/dispersion: Standard Deviation
GroupValueSpreadLowerUpperComment
Tinostamustine 180 mg/m^2-21.011.31Not reportedNot reportedNot reported
Tinostamustine 220 mg/m^24.02.83Not reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.73
        value
        4.0
      2. group Id
        OG001
        spread
        3.06
        value
        0.3
    denoms
    1. counts
      1. group Id
        OG000
        value
        3
      2. group Id
        OG001
        value
        3
      units
      Participants
    title
    ALT: Change at Day 100
  2. categories
    1. measurements
      1. group Id
        OG000
        spread
        6.81
        value
        10.7
      2. group Id
        OG001
        spread
        5.13
        value
        14.7
    denoms
    1. counts
      1. group Id
        OG000
        value
        3
      2. group Id
        OG001
        value
        3
      units
      Participants
    title
    ALP: Change at Day 100
  3. categories
    1. measurements
      1. group Id
        OG000
        spread
        1.00
        value
        3.0
      2. group Id
        OG001
        spread
        4.36
        value
        2.0
    denoms
    1. counts
      1. group Id
        OG000
        value
        3
      2. group Id
        OG001
        value
        3
      units
      Participants
    title
    AST: Change at Day 100
  4. categories
    1. measurements
      1. group Id
        OG000
        spread
        11.31
        value
        -21.0
      2. group Id
        OG001
        spread
        2.83
        value
        4.0
    denoms
    1. counts
      1. group Id
        OG000
        value
        2
      2. group Id
        OG001
        value
        2
      units
      Participants
    title
    Lactate dehydrogenase: Change at Day 100
denoms
  1. counts
    1. group Id
      OG000
      value
      3
    2. group Id
      OG001
      value
      3
    units
    Participants
description
Clinical serum chemistry tests included liver function parameters i.e. Alanine aminotransferase (ALT), Alkaline phosphatase (ALP), Aspartate aminotransferase, (AST) and Lactate dehydrogenase. Change from baseline in clinical serum chemistry tests i.e. liver function parameters at Day 100 were reported.
dispersion Type
Standard Deviation
groups
  1. description
    Participants received single dose of tinostamustine 180 mg/m\^2 IV injection on Day -1 followed by ASCT on Day 1.
    id
    OG000
    title
    Tinostamustine 180 mg/m^2
  2. description
    Participants received single dose of tinostamustine 220 mg/m\^2 IV injection on Day -1 followed by ASCT on Day 1.
    id
    OG001
    title
    Tinostamustine 220 mg/m^2
param Type
MEAN
population Description
Safety population included all participants who received tinostamustine. The study was early terminated on 17 April 2019, due to safety signals during Phase 1, participants were not enrolled in Phase 2. Here, number analyzed refers to the number of participants with available data for each specified category.
reporting Status
POSTED
time Frame
Baseline (Day -1), Day 100
title
Phase 1 and 2: Change From Baseline in Clinical Serum Chemistry Tests: Liver Function Parameters
type
SECONDARY
unit Of Measure
units per liter (U/L)

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice